Cytokine News and Research

RSS

Balanced production of pro and anti-inflammatory cytokines at two years of age protects against malaria

A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by the Barcelona Institute for Global Health (ISGlobal), an institution supported by "la Caixa" Foundation.

14 Nov 2018

Study shows new emerging role of osteopontin in HCV-related hepatocellular carcinoma

Hepatitis C virus (HCV) infection is the major cause of hepatocellular carcinoma (HCC) and was estimated to be responsible for 745,000 deaths in 2012.

13 Nov 2018

Inexpensive and effective drug does not reduce major adverse cardiovascular event rates

When it comes to reducing inflammation to decrease the risk of heart disease and stroke, results from the much-anticipated Cardiovascular Inflammation Reduction Trial indicate that targeting the right inflammatory pathways in at-risk patients is crucial.

12 Nov 2018

Researchers identify pathway to resolve allergic asthma

A group of Brazilian researchers succeeded in preventing allergic asthma from progressing in experimental models by increasing the amount of a protein. This increase, in turn, blocked the CD4+ T lymphocytes responsible for producing a cytokine that triggers a cascade of events resulting in the onset and progression of the disease.

6 Nov 2018

Scientists discover biomarkers for Zika-related birth defects

Scientists at USC have discovered biomarkers for fetal birth defects in the blood of pregnant women infected with Zika.

2 Nov 2018

Cytokine levels could predict autoimmune reactions to cancer immunotherapy

The development of immunotherapy, which mobilizes the body's own immune system to destroy cancer cells, is one of the greatest advances in cancer treatment, but immunotherapy can cause harm to healthy tissue in some patients.

31 Oct 2018

Researchers identify new potential target to inhibit progression of liver disease

Naglaa Shoukry, Ph. D., and her team have made a significant breakthrough in their research aiming to limit the progression of liver disease.

26 Oct 2018

Kent State professor receives NIH grant to study neurological roots of fear memories

People who suffer trauma will, with few exceptions, never forget what happened to them, but a Kent State University researcher may be able to offer them the hope of living without constant fear and anxiety.

25 Oct 2018

Modeling Alzheimer’s Disease Using Microfluidics

An interview with Dr. Joseph Park, the incorporation of astrocytes into the Alzheimer’s-in-a-dish culture system and it's applications in drug development.

24 Oct 2018

FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma

EUSA Pharma welcomes the news that FOTIVDA (tivozanib) is expected to be included in the upcoming European Society of Medical Oncology clinical practice guidelines for advanced renal cell carcinoma, anticipated to be published at the end of this year.

22 Oct 2018

Immune therapy may be potential treatment option for patients with hard-to-treat ankylosing spondylitis

Results from a phase 3 clinical trial indicate that patients who have not benefited from standard therapy for ankylosing spondylitis, a chronic inflammatory disease characterized by back pain and sacroiliac-joint damage, may have another treatment option in the biologic drug ixekizumab.

22 Oct 2018

Study shows close link between cytokine interleukin-1ß and obesity-promoted colon cancer

A new study describes the mechanistic relationship between the cytokine interleukin-1β, (IL-1β) and obesity, showing that when IL-1β levels are increased in obesity, IL-1 receptor signaling activates multiple pathways leading to colon cancer.

18 Oct 2018

New findings reveal potential cellular players in tumor microenvironment

New findings presented today by CytoReason reveals possible new cellular players in the tumor microenvironment that could impact the treatment process for the most in-need patients - those who have already failed to respond to ipilimumab (anti-CTLA4) immunotherapy.

16 Oct 2018

Allele awarded NIH grant to develop nanoantibody therapies for treatment of sepsis

The National Institute of General Medical Sciences of NIH has awarded a Small Business Innovative Research grant to Allele Biotechnology and Pharmaceuticals to develop new single-domain nanoantibody therapies for the treatment of sepsis.

15 Oct 2018

Researchers find potential treatment to halt premature labor and birth

Premature birth is the leading cause of infant death and disability in the U.S., and costs billions in dollars and heartache every year. Now, University of Connecticut researchers report in Reproductive Sciences a potential treatment that could stop many cases of premature labor and birth in their tracks.

15 Oct 2018

Cytokine News and Research

Balanced production of pro and anti-inflammatory cytokines at two years of age protects against malaria

Study shows new emerging role of osteopontin in HCV-related hepatocellular carcinoma

Inexpensive and effective drug does not reduce major adverse cardiovascular event rates

Researchers identify pathway to resolve allergic asthma

Scientists discover biomarkers for Zika-related birth defects

Cytokine levels could predict autoimmune reactions to cancer immunotherapy

Researchers identify new potential target to inhibit progression of liver disease

Kent State professor receives NIH grant to study neurological roots of fear memories

Modeling Alzheimer’s Disease Using Microfluidics

FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma

Immune therapy may be potential treatment option for patients with hard-to-treat ankylosing spondylitis

Study shows close link between cytokine interleukin-1ß and obesity-promoted colon cancer

New findings reveal potential cellular players in tumor microenvironment

Allele awarded NIH grant to develop nanoantibody therapies for treatment of sepsis

Researchers find potential treatment to halt premature labor and birth

Scientists work to speed regeneration and recovery of your sense of taste

Study analyzes distribution of two cytokines in sections of carotid atherosclerotic plaques

Genetic variants reveal novel therapeutic targets for chronic kidney disease

Axol's Human iPSC-derived Microglia for neuroimmunology research

OrthoSera presents first-in-man study results of hyperacute serum in knee osteoarthritis

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News